Clinical

Which immunizations should patients with inflammatory bowel disease receive?
Canadian Association of Gastroenterology issues clinical practice guidelines for use of live and inactivated vaccines in adults and children with IBD.
Pulmonary hypertension isn't as rare as once thought, but new treatments gaining ground
The past two decades have seen improved diagnosis for pulmonary hypertension (PH) along with a variety of new targeted treatments, according to recently released joint position statement issued by the Canadian Cardiovascular Society and the Canadian Thoracic Society.

Need a house call with your prescription? Mednow adds home visits to pharmacy services

By acquiring Medvisit—the country's largest provider of physician house calls—Mednow brings the 'last mile of healthcare' to its pharmacy-first strategy.
LET'S TALK: Ontario optometrists agree to mediation but still won't see OHIP patients starting in September

Until the Ontario Ministry of Health recognizes that the province needs to cover optometrists' cost of delivering eye care, OHIP patients are out of luck
Manna from heaven? It could be rabies vaccine bait if you’re in eastern Ontario

Don't touch or eat—not that you would—these blister-packed bait vaccines, which will be airdropped starting mid-August for foxes, raccoons and skunks.
No vax, no visit? What to know and what to do with unvaccinated patients

Physicians are divided over whether or not to see unvaccinated patients in person. In reality, the answer isn't up to them but rather to their provinces and regulatory bodies. Doctors can, however, control how they see and manage the unvaxxed.
KETO QUIZ: What do you know about low-carb diets?

With many patients still facing pandemic weight gain, the ketogenic diet is a popular option for weight reduction. But is it the best option?
Household products increase the risk of asthma

Products commonly used in the home should carry a warning that they increase the risk of asthma, according to a meta-analysis conducted by the University of Exeter.
Third monoclonal antibody approved for treating mild/moderate COVID-19 in high-risk outpatients

Health Canada grants Interim Order authorization for GSK’s single-dose monoclonal antibody, sotrovimab, for adults and adolescents.
Biologics and targeted therapy for severe refractory asthma

According to Asthma Canada, 3.8-million Canadians suffer from this chronic inflammatory condition and estimates 250,000 have severe asthma. Asthma has entered the era of personalized medicine with therapies that target specific inflammatory pathways in people with severe disease who don’t respond to normal inhaler therapy.